This study demonstrated that Ki-67/podoplanin double immunostaining expression correlated with the histopathological grade of HNSCC, suggesting that these markers are reliable in the clinical use and prognosis of cancer patients. This evidence concerns the gene MKI67 and head and neck squamous cell carcinoma.